Compugen (CGEN) EBIT Margin (2009 - 2026)
Compugen's EBIT Margin came in at -1032.71% for Q2 2026, up 973.58 percentage points from -2006.28% a year earlier but down 1447.09 percentage points from the prior quarter.
Powered by 
Analysis
Compugen (CGEN) EBIT Margin (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Compugen reported EBIT Margin of 40.94%, up 130.40 percentage points year-over-year; for FY2025, it was 43.05%, up 96.49 percentage points from FY2024.
- EBIT Margin carries a five-year change of +1617.85 percentage points (FY2020 to FY2025).
- Going back by year, EBIT Margin was -53.44% in FY2024 (-14.61 pp), -38.83% in FY2023 (+432.82 pp), -471.65% in FY2022 (+112.91 pp) and -584.57% in FY2021 (+990.23 pp).
- The five-year range for quarterly EBIT Margin is -2006.28% (Q2 2025) to 414.38% (Q1 2026).
- Year-over-year, EBIT Margin has increased for three consecutive quarters, with an average year-over-year change of -82.92 percentage points over the last six quarters.
- Business Quant data shows CGEN's EBIT Margin at 414.38% (Q1 2026), 83.23% (Q4 2025) and -417.40% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Compugen | 197.62 Mn | -218.36 Mn | 1.42 Mn | -179.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -179.17% |
| Jun 30, 2026 | -1,032.71% |
| Mar 31, 2026 | 414.38% |
| Dec 31, 2025 | 83.23% |
| Sep 30, 2025 | -417.40% |
| Jun 30, 2025 | -2,006.28% |
| Mar 31, 2025 | 367.56% |
| Dec 31, 2024 | -508.70% |
| Sep 30, 2024 | 26.24% |
| Jun 30, 2024 | -304.33% |
| Mar 31, 2024 | 331.85% |
| Sep 30, 2018 | -42.72% |
| Mar 31, 2018 | 1.15% |
| Dec 31, 2016 | -16,484.91% |
| Sep 30, 2016 | -11,381.43% |
| Jun 30, 2016 | -1,412.90% |
| Mar 31, 2016 | -9,538.71% |
| Dec 31, 2015 | -8.75% |
| Sep 30, 2015 | -3,019.21% |
| Jun 30, 2015 | -3,117.94% |
API Access
Compugen EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=CGEN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "CGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=CGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();